Analysed SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) News Sources
Biotech Week Ahead: XLV Beats The Market — Here Are The Stocks, Readouts And Events To Watch Next
21-09-2026
stocktwits.com
SLS Stock Slips Overnight Ahead Of Pancreatic Cancer Conference — Retail Looks For Clues To SLS009’s Next Trial
24-09-2026
stocktwits.com
SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
25-09-2026
yahoo.com
SLS Stock Slips 3% As Pancreatic Cancer Lab Data Leave REGAL Wait Unanswered
25-09-2026
stocktwits.com
Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?
30-09-2026
stocktwits.com
SELLAS Life Sciences Group (SLS) Could Be Fully Priced After Fresh SLS009 Pancreatic Data
30-09-2026
yahoo.com
SELLAS Life Sciences Group (SLS) Stock May Be Trading At A Premium On Fresh Pancreatic Cancer Data
30-09-2026
yahoo.com
Can SELLAS Life Sciences (SLS) Turn Early CDK9 Pancreatic Data Into a Durable Oncology Edge?
01-10-2026
yahoo.com
Despite Heavy Hedge Fund Support, Why Sellas Life Sciences (SLS) Fell 16.6% in Q3
01-10-2026
yahoo.com
What is the current price of SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ)?
The current price of SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) is $11.65.
SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) absolute price change since previous trading day?
The absolute price change of SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) since the previous trading day is $0.39.
SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) percentage price change since previous trading day?
The percentage price change of SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) since the previous trading day is 3.4636%.
What is the most recent average sentiment score for SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ)?
The most recent average sentiment score for SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ)?
The most recent sentiment for SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) is .
SEC-8K** Filing Available For SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.